These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8529281)

  • 1. Schedule-dependent synergism of taxol or taxotere with edatrexate against human breast cancer cells in vitro.
    Chou TC; Otter GM; Sirotnak FM
    Cancer Chemother Pharmacol; 1996; 37(3):222-8. PubMed ID: 8529281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Schedule-dependent synergism of edatrexate and cisplatin in combination in the A549 lung-cancer cell line as assessed by median-effect analysis.
    Perez EA; Hack FM; Webber LM; Chou TC
    Cancer Chemother Pharmacol; 1993; 33(3):245-50. PubMed ID: 8269606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
    Holmes FA
    Semin Oncol; 1996 Oct; 23(5 Suppl 11):46-56. PubMed ID: 8893900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computerized quantitation of synergism and antagonism of taxol, topotecan, and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design.
    Chou TC; Motzer RJ; Tong Y; Bosl GJ
    J Natl Cancer Inst; 1994 Oct; 86(20):1517-24. PubMed ID: 7932806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Omega-6 polyunsaturated fatty acid gamma-linolenic acid (18:3n-6) enhances docetaxel (Taxotere) cytotoxicity in human breast carcinoma cells: Relationship to lipid peroxidation and HER-2/neu expression.
    Menendez JA; Ropero S; Lupu R; Colomer R
    Oncol Rep; 2004 Jun; 11(6):1241-52. PubMed ID: 15138562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro comparative evaluation of trastuzumab (Herceptin) combined with paclitaxel (Taxol) or docetaxel (Taxotere) in HER2-expressing human breast cancer cell lines.
    Merlin JL; Barberi-Heyob M; Bachmann N
    Ann Oncol; 2002 Nov; 13(11):1743-8. PubMed ID: 12419746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schedule-dependent synergism and antagonism between paclitaxel and methotrexate in human carcinoma cell lines.
    Kano Y; Akutsu M; Tsunoda S; Furuta M; Yazawa Y; Ando J
    Oncol Res; 1998; 10(7):347-54. PubMed ID: 10063968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of the synergistic interaction of edatrexate and cisplatin in vitro.
    Chou TC; Tan QH; Sirotnak FM
    Cancer Chemother Pharmacol; 1993; 31(4):259-64. PubMed ID: 8422687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergism of cytotoxic effects of vinorelbine and paclitaxel in vitro.
    Budman DR; Calabro A; Wang LG; Liu XM; Stiel L; Adams LM; Kreis W
    Cancer Invest; 2000; 18(8):695-701. PubMed ID: 11107439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro evaluation of schedule-dependent interactions between docetaxel and doxorubicin against human breast and ovarian cancer cells.
    Zeng S; Chen YZ; Fu L; Johnson KR; Fan W
    Clin Cancer Res; 2000 Sep; 6(9):3766-73. PubMed ID: 10999771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro search for synergy and antagonism: evaluation of docetaxel combinations in breast cancer cell lines.
    Budman DR; Calabro A
    Breast Cancer Res Treat; 2002 Jul; 74(1):41-6. PubMed ID: 12150451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Docetaxel in breast cancer and a rationale for combination therapy.
    Hortobágyi G
    Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):11-5. PubMed ID: 9213321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxoids in combination chemotherapy for metastatic breast cancer.
    Dieras V; Fumoleau P; Bourgeois H; Misset JL; Azli N; Pouillart P
    Anticancer Drugs; 1996 Aug; 7 Suppl 2():47-52. PubMed ID: 8862712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD; Shivers RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pharmacological study of weekly docetaxel in patients with metastatic breast cancer].
    Kim Y; Takatsuka Y; Gotoh K; Hasegawa S; Aritake N; Kan K; Fukunaga M; Touno T; Oozato H; Imamoto H; Yamazaki K; Maruyama H
    Gan To Kagaku Ryoho; 1999 Sep; 26(10):1437-41. PubMed ID: 10500531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Docetaxel alone or orally combined with 5-fluorouracil and its derivatives: effects on mouse mammary tumor cell line MM2 in vitro and in vivo.
    Takeda Y; Yoshizaki I; Nonaka Y; Yanagie H; Matsuzawa A; Eriguchi M
    Anticancer Drugs; 2001 Sep; 12(8):691-8. PubMed ID: 11604557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedule-dependent interactions between vinorelbine and paclitaxel in human carcinoma cell lines in vitro.
    Kano Y; Akutsu M; Suzuki K; Ando J; Tsunoda S
    Breast Cancer Res Treat; 1999 Jul; 56(1):79-90. PubMed ID: 10517345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Herceptin and taxanes.
    Diéras V; Beuzeboc P; Laurence V; Pierga JY; Pouillart P
    Oncology; 2001; 61 Suppl 2():43-9. PubMed ID: 11694787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel enhances the cytotoxicity of tetrahydropyranyladriamycin in a sequence-dependent manner.
    Egawa T; Kubota T; Furukawa T; Otani Y; Watanabe M; Furukawa T; Kumai K; Kitajima M
    Anticancer Res; 2001; 21(4A):2597-600. PubMed ID: 11724327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.